The case for cryoablation of prostate cancer

Journal of Endourology

Volumn 22, Issue 9, 2008, Pages 2057-2058

  Rukstalis, Daniel B ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CONFERENCE PAPER; CRYOABLATION; DOPPLER FLOWMETRY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; TREATMENT PLANNING;

AGED; CRYOSURGERY; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 52449096463     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.9745     Document Type: Conference Paper

References (16)

1. Walsh RM, Thompson IM. Prostate cancer screening and disease management: How screening may have an unintended effect on survival and mortality - the camel's nose effect. J Urol 2007;177:1303-1306.
2. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007;177:2106-2131.
3. Chan LW, Stamey TA. Calculating prostate cancer volume preoperatively: The D'Amico equation and some other observations. J Urol 1998;159:1998-2003.
4. Wise AM, Stamey TA, McNeal JE, Clayton JL. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002;60:264-269.
5. Rukstalis DB, Goldknopf JL, Crowley EM, Garcia FU. Prostate cryoablation: A scientific rationale for future modifications. Urology 2002;60(suppl 1):19-25.
6. Pelzer AE, Bektic J, Akkad T, et al. Under diagnosis and over diagnosis of prostate cancer in a screening population with serum PSA 2 to 10 ng/ml. J Urol 2007;178:93-97.
7. Huang WC, Kuroiwa K, Serio AM, Bianco FJ Jr, Fine SW, Shayegan B, Scardino PT, Eastham JA. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol 2007;177:1324-1329.
8. Walz J, Graefen M, Huland H. Basic principles of anatomy for optimal surgical treatment of prostate cancer. World J Urol 2007;25:31-38.
9. Bahn DK, Lee F, Badalament R, Kuman a, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002;60(suppl 1):3-11.
10. Bahn DK, Silverman P, Lee F Sr, Badalament R, Bahn ED, Rewcastle JC. Focal prostate cryoablation: Initial results show cancer control and potency preservation. J Endourol 2006;20:688-692.
11. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: A new approach to preserving potency. Urology 2002;60:109-114.
12. Mullerad M, Hricak H, Kuroiwa K, Pucar D, Chen HN, Kattan MW, Scardino PT. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005;174:2158-2163.
13. Epstein JI, Sanderson H, Carter HB, Scharfstein DO. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 2005;66:356-360.
14. Descazeaud A, Rubin M, Chemama S, et al. Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen. World J Urol 2006;24:676-680.
15. Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006;175:485-488.
16. Benoit RM, Cohen JK, Miller RJ Jr. Comparison of the hospital costs for radical prostatectomy and cryosurgical ablation of the prostate. Urology 1998;52:820-824.